Johnson & Johnson has a chance to show it’s more than just a rotation winner
Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…
Business Watch: AkzoNobel gets another takeover offer; ARPA-H launches rare disease program
When hostilities started heating up again in and around the Strait of Hormuz last week, my first reaction…
Kennedy presses ahead with plans to reduce antidepressant use
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
GLP-1 implant from Vivani Medical aims to help patients stay on treatment
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
AstraZeneca’s trial flop raises bigger questions around its pipeline
AstraZeneca‘s failed late-stage trial for Wainua was never expected to have a major financial impact on the company.…
How one father built a biotech, Grace Science, to save his daughter
Highlights Matt Wilsey has spent a decade and $70 million trying to develop a cure for his daughter…
AstraZeneca, Ionis report major trial failure with heart disease drug
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug…
Business Watch: Anthropic launches Claude Science; AstraZeneca links with CSPC again
The latest edition of C&EN’s Global Top 50 chemical firms has arrived. Owing to changes to C&EN’s…
Colorado’s first-of-its-kind price cap on an Amgen drug blocked
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Widely used pandemic pharmaceuticals harm marine aquatic ecosystems
A new study published in New Contaminants suggests that several drugs widely used during the COVID-19 pandemic can…
Anthropic launches AI drug discovery program, Claude Science
CEO of Anthropic Dario Amodei attends a working lunch with G7 leaders, G7 outreach partners and global tech…